BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 2667936)

  • 1. Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.
    Buckley MM; Goa KL; Price AH; Brogden RN
    Drugs; 1989 Jun; 37(6):761-800. PubMed ID: 2667936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia.
    Cortese C; Marenah CB; Miller NE; Lewis B
    Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of familial and non-familial hypercholesterolaemia: a review of HMG-CoA reductase inhibitors and probucol.
    Tikkanen MJ; Helve E; Nikkilä EA
    Eur Heart J; 1987 Aug; 8 Suppl E():97-101. PubMed ID: 3315684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probucol (Lorelco) in treatment of hyperlipemia.
    Murphy BF
    JAMA; 1977 Dec; 238(23):2537-8. PubMed ID: 199758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis.
    Glueck CJ
    Ann Intern Med; 1982 Apr; 96(4):475-82. PubMed ID: 7039445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Probucol treatment of hyperlipidemia].
    Koizumi J
    Nihon Rinsho; 1994 Dec; 52(12):3279-84. PubMed ID: 7853723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of homozygous familial hypercholesterolaemia with probucol.
    Baker SG; Joffe BI; Mendelsohn D; Seftel HC
    S Afr Med J; 1982 Jul; 62(1):7-11. PubMed ID: 7089781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, placebo-controlled, cross-over trial of probucol in heterozygous familial hypercholesterolaemia.
    Durrington PN; Miller JP
    Atherosclerosis; 1985 May; 55(2):187-94. PubMed ID: 3890872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profiles.
    Helve E; Tikkanen MJ
    Atherosclerosis; 1988 Aug; 72(2-3):189-97. PubMed ID: 3063268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia.
    Jones DB; Simpson HC; Slaughter P; Lousley S; Carter RD; Cobbe SM; Mann JI
    Atherosclerosis; 1984 Oct; 53(1):1-7. PubMed ID: 6388586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
    Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J
    Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of probucol on homozygous cases of familial hypercholesterolemia.
    Yamamoto A; Matsuzawa Y; Kishino B; Hayashi R; Hirobe K; Kikkawa T
    Atherosclerosis; 1983 Aug; 48(2):157-66. PubMed ID: 6615580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probucol in long-term treatment of hypercholesterolemia.
    Strandberg TE; Vanhanen H; Miettinen TA
    Gen Pharmacol; 1988; 19(3):317-20. PubMed ID: 3046993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of medium-term probucol treatment on plasma lipids and lipoproteins. 16 cases of type IIa and IIb hyperlipoproteinaemia (author's transl)].
    Rouffy J; Chanu B; Bakir R; Goy-Loepper J; Saya C
    Nouv Presse Med; 1980 Oct; 9(40):3014-7. PubMed ID: 7443443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with probucol of children with familial hypercholesterolaemia.
    Sanjurjo P; Martul P; Sasieta M; Lafuente P; Ariza F; Cabeza I
    Acta Paediatr Scand; 1988 Jan; 77(1):132-5. PubMed ID: 3285634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of probucol and cholestyramine combination therapy in severe familial hypercholesterolaemia.
    Jackson JM; Lee HA
    Atherosclerosis; 1984; 51(2-3):189-97. PubMed ID: 6743378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease.
    Kuo PT; Wilson AC; Kostis JB; Moreyra AE
    Am J Cardiol; 1986 Jun; 57(16):43H-48H. PubMed ID: 3524177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of probucol on plasma lipids and lipoproteins in type IIb hyperlipoproteinemia.
    Hunninghake DB; Bell C; Olson L
    Atherosclerosis; 1980 Nov; 37(3):469-74. PubMed ID: 7458992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of severe and mild hypercholesterolaemia with probucol and neomycin.
    Miettinen TA; Toivonen I
    Postgrad Med J; 1975; 51(8):suppl 71-5. PubMed ID: 215985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial.
    Valeri A; Gelfand J; Blum C; Appel GB
    Am J Kidney Dis; 1986 Dec; 8(6):388-96. PubMed ID: 3544820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.